Abstract In an article in this edition of the Journal of Muscle Research and Cell Motility, Geeves, HitchcockDiGregori and Gunning present a nomenclature founded on the gene and exon structure of tropomyosin that is both clear and unambiguous. Moreover, the authors have ensured that the new names are linked with their sequences in the NCBI database, thus eliminating the uncertainty of linking a protein isoform with its sequence. This nomenclature system has been planned with the support of all the major labs that work with tropomyosin. We recommend that all researchers take note of this scheme and use it.
Tropomyosin has a long history, being the third muscle protein to be described (by Bailey in 1948) . It is a deceptively simple molecule, being almost completely alphahelical, having 284 or 248 amino acids and forming a dimer that has been considered a paradigm of coiled-coil proteins. The spectrum of tropomyosin structure and function was recently highlighted in a special edition of the Journal of Muscle research and Cell Motility (Vol 34 issues [3] [4] 2013) . Tropomyosin is expressed in multiple tissuespecific isoforms from multiple genes. Many of the variants of tropomyosin have been known since the birth of gel electrophoresis and amino acid sequencing techniques, but, apart from a few ubiquitous variants such as the a and b isoforms of skeletal muscle, they have been identified by a bewildering collection of names.
The true relationship between tropomyosin variants was revealed by DNA sequencing, unfortunately this happened after many of the tropomyosin variant names had been established. There are four genes (TPM1-4) and each is made up of 10-15 exons. Exons 1, 2, 6 and 9 are alternatively spliced to yield many tissue specific isoforms, having nine exons and 284 amino acids or eight exons and 248 amino acids. The naming of tropomyosin variants has now reached a state of considerable confusion, since the historical nomenclature and the genetic nomenclature do not match in many cases. What is needed is a rational nomenclature that reflects the true origin of the isoform as defined by sequence databases. This is what Geeves et al. (2014) have done. In their article in this issue of Journal of Muscle Research and Cell Motility, they present a nomenclature founded on the gene and exon structure of tropomyosin that is both clear and unambiguous. Moreover, the authors have ensured that the new names are linked with their sequences in the NCBI database, thus eliminating at last the uncertainty of linking protein isoform with its sequence. This nomenclature system has been planned with the support of all the major labs that work with tropomyosin. We recommend all researchers to take note of this scheme AND TO USE IT.
